These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8310162)

  • 1. Risk assessment for aflatoxin: an evaluation based on the multistage model.
    Bowers J; Brown B; Springer J; Tollefson L; Lorentzen R; Henry S
    Risk Anal; 1993 Dec; 13(6):637-42. PubMed ID: 8310162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment for aflatoxin: III. Modeling the relative risk of hepatocellular carcinoma.
    Hoseyni MS
    Risk Anal; 1992 Mar; 12(1):123-8. PubMed ID: 1315449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aflatoxin, hepatitis and worldwide liver cancer risks.
    Henry SH; Bosch FX; Bowers JC
    Adv Exp Med Biol; 2002; 504():229-33. PubMed ID: 11922091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.
    Wild CP; Jansen LA; Cova L; Montesano R
    Environ Health Perspect; 1993 Mar; 99():115-22. PubMed ID: 8391433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aflatoxin biomarkers.
    Hall AJ; Wild CP
    Lancet; 1992 Jun; 339(8806):1413-4. PubMed ID: 1350820
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
    Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment for aflatoxin: II. Implications of human epidemiology data.
    Bruce RD
    Risk Anal; 1990 Dec; 10(4):561-9. PubMed ID: 2287783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland.
    Peers F; Bosch X; Kaldor J; Linsell A; Pluijmen M
    Int J Cancer; 1987 May; 39(5):545-53. PubMed ID: 3570547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.
    Groopman JD; Johnson D; Kensler TW
    Cancer Biomark; 2005; 1(1):5-14. PubMed ID: 17192028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary liver cancer is of multifactorial origin: importance of hepatitis B virus infection and dietary aflatoxin.
    Saracco G
    J Gastroenterol Hepatol; 1995; 10(5):604-8. PubMed ID: 8963039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach.
    Sylla A; Diallo MS; Castegnaro J; Wild CP
    Mutat Res; 1999 Jul; 428(1-2):187-96. PubMed ID: 10517992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study.
    Srivatanakul P; Parkin DM; Jiang YZ; Khlat M; Kao-Ian UT; Sontipong S; Wild C
    Cancer; 1991 Dec; 68(11):2411-7. PubMed ID: 1657355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
    Autrup H; Seremet T; Wakhisi J; Wasunna A
    Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: from gene to public health.
    Montesano R; Hainaut P; Wild CP
    J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
    Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
    Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Longitudinal study of aflatoxin exposure in the development of primary liver cancer in patients with chronic hepatitis].
    Lu PX; Wang JB; Zhang QN; Wu Y; Sun Y; Chen TY
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(24):1665-9. PubMed ID: 20979873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment for aflatoxin B1: a modeling approach.
    Wu-Williams AH; Zeise L; Thomas D
    Risk Anal; 1992 Dec; 12(4):559-67. PubMed ID: 1336206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA
    IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.